MEDS

Conviction 100Consumer StaplesScan · Wed, Sep 16, 2026

DataMeds AI, Inc. (MEDS) closed at $1.62 (+87.22%) on Sep 16, 2026. Price is below its 50-day. RSI(14) 49, -92.8% from its 52-week high, -54.8% year to date. Sector: Consumer Staples · Wholesale-Drugs, Proprietaries & Druggists' Sundries.

MEDS$1.62+87.22%

ResistanceSupportVol 14

Aug 31Sep 2Sep 4Sep 9Sep 11Sep 15

WSB mentions · 24h changelatest +2400.00%· 25 mentions

Aug 31Sep 2Sep 4Sep 9Sep 11Sep 15

DataMeds AI, Inc.Wholesale-Drugs, Proprietaries & Druggists' Sundries

Price1.62

Change+87.22%

Gap+3.42%

Rel volume97.51×

Avg volume3.9M

Avg $ vol5.97M

SMA 201.13

SMA 502.96

SMA 200—

Price vs 50-45.24%

Price vs 200—

MA stack—

50/200 cross—

Supertrendup · 1.05

RSI (14)49

MACD hist0.19

MACD cross—

Stoch %K / %D26 / 16

ADX (14)39

+DI / −DI57 / 16

RSI divergenceBullish

MACD divergence—

ATR %+25.90%

ADR %19.31%

52w high22.42

52w low0.8510

From 52w high-92.77%

Above 52w low+90.36%

New 52w highNo

SqueezeOn · 1d

Bollinger width85.30%

%B1.01

Donchian pos26.34%

Donchian high3.85

Donchian low0.8225

AVWAP (52w high)2.29

vs AVWAP high-29.18%

AVWAP (52w low)1.97

vs AVWAP low-17.77%

OBV trendUp

Chaikin MF (20)-0.38

Today vs 20d97.51×

Avg vol (14d)5.52M

Avg vol (20d)3.9M

Avg $ vol (20d)5.97M

Market cap4.96M

RS 3m (vs SPY)—

RS 6m (vs SPY)—

RS line new highNo

Trend template—

Technical rank56.7

1 week+85.97%

1 month+9.46%

3 months-80.65%

6 months—

1 year—

YTD-54.75%

P/E-0.05

P/B-0.25

P/S0.21

P/FCF—

EPS-1.43

Div yield—

ROE519.24%

ROA-309.15%

Debt/Eq-0.97

Current0.14

EV/EBITDA-0.24

Gross margin-27.54%

Net margin-433.95%

Rev growth28.73%

EPS growth-1377.12%

Price target—

Target upside—

Analyst rating—

Institutional2.15%

Ent. value21.5M

Revenue1.78M

Net income-18.36M

Gross profit182.2K

Free cash flow—

IndustryWholesale-Drugs, Proprietaries & Druggists' Sundries

ExchangeNasdaq

Shares out—

Employees—

Listed—

Free float3.06M

Float %100.0%

Short interest173.99K

Days to cover0.2d

Short volume54.3%

Squeeze score37 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA+

Conviction100 / 100

Pattern quality—

Tech rank56.7 / 100

Group rank—

Status lane—

Setup direction—

Pattern family

Resistance3.81

Support0.8363

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in MEDS

All disclosures →

No recent disclosed trades by Congress in MEDS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in MEDS

No recent insider (Form 4) filings in MEDS. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in MEDS · 7 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.

MEDS

Recent news

Get daily signals & real-time alerts.